肥胖在子宫内膜癌风险、预防和治疗中的作用
与许多其他癌症类型形成鲜明对比,子宫内膜癌的发病率和死亡率持续增长,这一不良趋势在很大程度上归因于全球肥胖流行。目前超过一半的子宫内膜癌可归因于肥胖,肥胖被认定为该疾病的独立危险因素。本综述识别了肥胖和脂肪组织参与子宫内膜癌发病的分子机制,进一步讨论了肥胖对疾病临床管理的影响,并审视了旨在降低子宫内膜癌风险、改善癌症结局以及在日益年轻化的患者群体中保留生育功能的合理行为和药物干预措施的开发。
要点
- 子宫内膜癌发病率和死亡率持续增长,很大程度上归因于全球肥胖流行。
- 超过一半的子宫内膜癌可归因于肥胖,肥胖是独立危险因素。
- 综述探讨肥胖影响临床管理及降低风险、改善结局和保留生育的干预措施。
核心结论
- 肥胖是子宫内膜癌的独立危险因素,超过一半的子宫内膜癌可归因于肥胖。
研究设计与样本
- 综述,识别肥胖和脂肪组织参与子宫内膜癌发病的分子机制。
主要发现
- 子宫内膜癌发病率和死亡率持续增长,与全球肥胖流行密切相关。
- 超过一半的子宫内膜癌目前可归因于肥胖。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In sharp contrast to many other cancer types, the incidence and mortality of endometrial cancer continue to grow. This unfortunate trend is, in no small part, a result of the worldwide obesity epidemic. More than half of endometrial cancers are currently attributable to obesity, which is recognized as an independent risk factor for this disease. In this review, we identify the molecular mechanisms by which obesity and adipose tissue contribute to the pathogenesis of endometrial cancer. We further discuss the impact of obesity on the clinical management of the disease and examine the development of rational behavioral and pharmaceutical interventions aimed at reducing endometrial cancer risk, improving cancer outcomes, and preserving fertility in an increasingly younger population of patients with endometrial cancer.
引用
- Onstad MA, Schmandt RE, Lu KH, et al. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. J Clin Oncol. 2016. PMID: 27903150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。